Immuneering (IMRX) Current Leases (2020 - 2024)
Immuneering (IMRX) has 5 years of Current Leases data on record, last reported at $324702.0 in Q3 2024.
- For Q3 2024, Current Leases rose 7.65% year-over-year to $324702.0; the TTM value through Sep 2024 reached $324702.0, up 7.65%, while the annual FY2023 figure was $300107.0, 20.76% down from the prior year.
- Current Leases reached $324702.0 in Q3 2024 per IMRX's latest filing, up from $311459.0 in the prior quarter.
- Across five years, Current Leases topped out at $378723.0 in Q4 2022 and bottomed at $76322.0 in Q4 2020.
- Average Current Leases over 5 years is $265688.5, with a median of $300107.0 recorded in 2023.
- Peak YoY movement for Current Leases: soared 272.84% in 2022, then decreased 20.76% in 2023.
- A 5-year view of Current Leases shows it stood at $76322.0 in 2020, then skyrocketed by 259.06% to $274039.0 in 2021, then surged by 38.2% to $378723.0 in 2022, then fell by 20.76% to $300107.0 in 2023, then increased by 8.2% to $324702.0 in 2024.
- Per Business Quant database, its latest 3 readings for Current Leases were $324702.0 in Q3 2024, $311459.0 in Q2 2024, and $298543.0 in Q1 2024.